Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Truist Securities Downgrades Red Rock Resorts to Hold

Truist Securities Downgrades Red Rock Resorts to Hold

Truist Securities analyst Barry Jonas downgrades Red Rock Resorts (NASDAQ:RRR) from Buy to Hold.

byBenzinga Newsdesk

January 11, 2023

1 minute read

Truist Securities analyst Barry Jonas downgrades Red Rock Resorts (NASDAQ:RRR) from Buy to Hold.

Why Recently-Listed Haoxi Health Technology Shares Are Falling Today

By Nabaparna Bhattacharya

January 31, 8:42 AM

Haoxi Health Technology experiences a decline in its shares after closing its initial public offering at $4.00 per share, raising $9.60 million for general purposes.

HAO

Jefferies Downgrades Golden Entertainment to Hold, Announces $43 Price Target

By Benzinga Newsdesk

January 9, 6:03 AM

Jefferies analyst Cassandra Lee downgrades Golden Entertainment (NASDAQ:GDEN) from Buy to Hold and announces $43 price target.

GDEN

Analyst Ratings

Evaluating Generac Hldgs: Insights From 4 Financial Analysts

By Benzinga Insights

February 12, 5:01 PM

In the last three months, 4 analysts have published ratings on Generac Hldgs (NYSE:GNRC), offering a diverse range…

GNRC

PharmaCyte Biotech Announces Cash Tender Offer For Up To 7.75M Shares At $3.25 Per Share

By Happy Mohamed

May 11, 8:35 AM

Concurrently, the Company Announces $35 Million Financing of Convertible Preferred Stock at $4.00 per Share PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the

PMCB

Truist Securities Downgrades Red Rock Resorts to Hold

Related Posts

Why Recently-Listed Haoxi Health Technology Shares Are Falling Today

Jefferies Downgrades Golden Entertainment to Hold, Announces $43 Price Target

Evaluating Generac Hldgs: Insights From 4 Financial Analysts

PharmaCyte Biotech Announces Cash Tender Offer For Up To 7.75M Shares At $3.25 Per Share